1. Home
  2. JCSE vs GNPX Comparison

JCSE vs GNPX Comparison

Compare JCSE & GNPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • JCSE
  • GNPX
  • Stock Information
  • Founded
  • JCSE 1999
  • GNPX 2009
  • Country
  • JCSE Singapore
  • GNPX United States
  • Employees
  • JCSE N/A
  • GNPX N/A
  • Industry
  • JCSE Miscellaneous manufacturing industries
  • GNPX Biotechnology: Pharmaceutical Preparations
  • Sector
  • JCSE Consumer Discretionary
  • GNPX Health Care
  • Exchange
  • JCSE Nasdaq
  • GNPX Nasdaq
  • Market Cap
  • JCSE 5.9M
  • GNPX 5.5M
  • IPO Year
  • JCSE 2022
  • GNPX 2018
  • Fundamental
  • Price
  • JCSE $1.20
  • GNPX $0.25
  • Analyst Decision
  • JCSE
  • GNPX
  • Analyst Count
  • JCSE 0
  • GNPX 0
  • Target Price
  • JCSE N/A
  • GNPX N/A
  • AVG Volume (30 Days)
  • JCSE 209.1K
  • GNPX 24.1M
  • Earning Date
  • JCSE 10-29-2025
  • GNPX 11-12-2025
  • Dividend Yield
  • JCSE 7.49%
  • GNPX N/A
  • EPS Growth
  • JCSE N/A
  • GNPX N/A
  • EPS
  • JCSE 0.00
  • GNPX N/A
  • Revenue
  • JCSE $14,126,397.00
  • GNPX N/A
  • Revenue This Year
  • JCSE N/A
  • GNPX N/A
  • Revenue Next Year
  • JCSE N/A
  • GNPX N/A
  • P/E Ratio
  • JCSE $245.80
  • GNPX N/A
  • Revenue Growth
  • JCSE 6.92
  • GNPX N/A
  • 52 Week Low
  • JCSE $0.86
  • GNPX $0.14
  • 52 Week High
  • JCSE $2.39
  • GNPX $3.97
  • Technical
  • Relative Strength Index (RSI)
  • JCSE 57.77
  • GNPX 55.24
  • Support Level
  • JCSE $1.02
  • GNPX $0.22
  • Resistance Level
  • JCSE $1.28
  • GNPX $0.32
  • Average True Range (ATR)
  • JCSE 0.12
  • GNPX 0.05
  • MACD
  • JCSE 0.01
  • GNPX 0.01
  • Stochastic Oscillator
  • JCSE 40.32
  • GNPX 40.15

About JCSE JE Cleantech Holdings Limited

JE Cleantech Holdings Ltd is engaged in the manufacturing and selling of cleaning systems and other equipment that can be categorized into four different categories, namely aqueous washing systems, plating and cleaning systems, train cleaning systems, and other equipment, such as filtration units. The product lives of its cleaning systems and other equipment ranges from two to ten years. The company is also into designing, developing, and manufacturing other cleaning systems for various industrial end-use applications using its R&D and engineering capabilities. The company derives the majority of its revenue from the Sales of cleaning systems and other equipment. Geographically, the company derives a majority of its revenue from Singapore, followed by Malaysia.

About GNPX Genprex Inc.

Genprex Inc is a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes. Its technologies are designed to administer disease-fighting genes to provide new therapies for large patient populations with cancer and diabetes who currently have limited treatment options. Genprex's oncology program utilizes its systemic, non-viral Oncoprex Delivery System which encapsulates the gene-expressing plasmids using lipid-based nanoparticles in a lipoplex form. The company's product candidate, Reqorsa Immunogene Therapy (quaratusugene ozeplasmid), is being evaluated in three clinical trials as a treatment for NSCLC and SCLC.

Share on Social Networks: